231 related articles for article (PubMed ID: 26159421)
1. Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.
Kozono D; Li J; Nitta M; Sampetrean O; Gonda D; Kushwaha DS; Merzon D; Ramakrishnan V; Zhu S; Zhu K; Matsui H; Harismendy O; Hua W; Mao Y; Kwon CH; Saya H; Nakano I; Pizzo DP; VandenBerg SR; Chen CC
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4055-64. PubMed ID: 26159421
[TBL] [Abstract][Full Text] [Related]
2. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
[TBL] [Abstract][Full Text] [Related]
3. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
[TBL] [Abstract][Full Text] [Related]
4. Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.
Yang CM; Chiba T; Brill B; Delis N; von Manstein V; Vafaizadeh V; Oellerich T; Groner B
Int J Cancer; 2015 Nov; 137(10):2296-309. PubMed ID: 25991553
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
[TBL] [Abstract][Full Text] [Related]
7. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
[TBL] [Abstract][Full Text] [Related]
8. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
9. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
[TBL] [Abstract][Full Text] [Related]
10. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription.
Amente S; Bertoni A; Morano A; Lania L; Avvedimento EV; Majello B
Oncogene; 2010 Jun; 29(25):3691-702. PubMed ID: 20418916
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
[TBL] [Abstract][Full Text] [Related]
12. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
13. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
14. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of Gas41 and Myc encoded by amplified genes in nervous system tumours.
Piccinni E; Chelstowska A; Hanus J; Widlak P; Loreti S; Tata AM; Augusti-Tocco G; Bianchi MM; Negri R
Acta Biochim Pol; 2011; 58(4):529-34. PubMed ID: 22068108
[TBL] [Abstract][Full Text] [Related]
16. LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response.
Faletti S; Osti D; Ceccacci E; Richichi C; Costanza B; Nicosia L; Noberini R; Marotta G; Furia L; Faretta MR; Brambillasca S; Quarto M; Bertero L; Boldorini R; Pollo B; Gandini S; Cora D; Minucci S; Mercurio C; Varasi M; Bonaldi T; Pelicci G
Sci Transl Med; 2021 Dec; 13(623):eabf7036. PubMed ID: 34878824
[TBL] [Abstract][Full Text] [Related]
17. SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicity.
Hiraoka K; Hayashi T; Kaneko R; Nasu-Nishimura Y; Koyama-Nasu R; Kawasaki Y; Akiyama T
Biochem Biophys Res Commun; 2015 May; 460(2):216-21. PubMed ID: 25770425
[TBL] [Abstract][Full Text] [Related]
18. The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1.
Ge W; Liu Y; Chen T; Zhang X; Lv L; Jin C; Jiang Y; Shi L; Zhou Y
Biomaterials; 2014 Jul; 35(23):6015-25. PubMed ID: 24794925
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells.
De Salvo M; Maresca G; D'agnano I; Marchese R; Stigliano A; Gagliassi R; Brunetti E; Raza GH; De Paula U; Bucci B
Int J Radiat Biol; 2011 May; 87(5):518-33. PubMed ID: 21405945
[TBL] [Abstract][Full Text] [Related]
20. Resetting cancer stem cell regulatory nodes upon MYC inhibition.
Galardi S; Savino M; Scagnoli F; Pellegatta S; Pisati F; Zambelli F; Illi B; Annibali D; Beji S; Orecchini E; Alberelli MA; Apicella C; Fontanella RA; Michienzi A; Finocchiaro G; Farace MG; Pavesi G; Ciafrè SA; Nasi S
EMBO Rep; 2016 Dec; 17(12):1872-1889. PubMed ID: 27852622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
